Staying Fit
Medicare has agreed to pay for two very expensive cancer treatments. Avastin, the controversial breast cancer treatment, that was denied by the FDA earlier this week, and Provenge, a treatment for advance stages of prostate cancer. Read
Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine.
Medicare has agreed to pay for two very expensive cancer treatments. Avastin, the controversial breast cancer treatment, that was denied by the FDA earlier this week, and Provenge, a treatment for advance stages of prostate cancer. Read
ARTICLE CONTINUES AFTER ADVERTISEMENT
AARP Value & Member Benefits
ADT™ Home Security
Savings on monthly home security monitoring
AARP® Staying Sharp®
Activities, recipes, challenges and more with full access to AARP Staying Sharp®